Filing metadata

Accession number
0001479290-23-000116
Form type
Form 4
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Dec 18, 2023
Reporting period
Dec 15, 2023
Description
Insider transaction

Explore SEC Filings Hub